郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist.

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2024作者：An-Na Moon; François Briand; Natalia Breyner; Dong-Keun Song; Martin Rønn Madsen; Hongbin Kim; Keonwoo Choi; Yoonsuk Lee; Wan Namkung
阅读更多 →

药效评价Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA.

期刊：Journal of advanced research发表年份：2024作者：Xi Dong; Shan Lu; Yu Tian; Han Ma; Yang Wang; Xuelian Zhang; Guibo Sun; Yun Luo; Xiaobo Sun
阅读更多 →

药效评价The antioxidant, anti-cholangiocarcinoma, and anti-Opisthorchis viverrini activities of ethanolic extract from Antidesma thwaitesianum fruit.

期刊：Journal of advanced veterinary and animal research发表年份：2024作者：Ratchadawan Aukkanimart; Pranee Sriraj; Areeya Changthong; Tichanon Promsrisuk
阅读更多 →

药效评价Methods comparison of two-dimensional gel electrophoresis for host cell protein characterization.

期刊：Biotechnology progress发表年份：2024作者：Abigail King; Yiwei Zhao; Alexandru Lazar; Margeaux Capron; Niranjan Thiruvur; Xinrong Liu
阅读更多 →